Salivary interleukin-6 (IL-6) demonstrates strong potential as a non-invasive biomarker forthe diagnosis and prognostication of oral squamous cell carcinoma, effectively distinguishing it from potentially malignant disordersand healthy individuals [11]. This evidence concerns the gene IL6 and oral cavity squamous cell carcinoma.